For the quarter ending 2026-03-31, INSP had -$5,881K decrease in cash & cash equivalents over the period. $3,123K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 204,583 | 269,077 | 642,904 | - |
| Cost of goods sold | 27,671 | 36,071 | 97,154 | - |
| Research and development expense | 25,826 | 24,942 | 78,223 | - |
| Selling, general and administrative expense (excluding advertising expense) | 130,558 | 129,093 | 380,619 | - |
| Advertising expense | 21,646 | 32,860 | 82,065 | - |
| Operating (loss) | -1,118 | 46,111 | 4,843 | - |
| Other income | 3,515 | 4,208 | 10,535 | - |
| Income tax expense | 13,691 | -85,771 | 6,046 | - |
| Impairment of strategic investment | - | 0 | 0 | 4,046 |
| Net (loss) earnings | -11,294 | 136,090 | 9,332 | - |
| Depreciation and amortization | 5,110 | 3,822 | 3,677 | 6,458 |
| Accretion of investment discount | 290 | 377 | 394 | 2,118 |
| Stock-based compensation expense | 30,689 | 28,012 | 29,467 | 72,780 |
| Deferred income taxes (benefit) | - | -88,749 | - | - |
| Deferred income tax expense | 1,009 | - | - | - |
| Provision for estimated credit losses | 186 | -18 | -132 | 350 |
| Other non-cash expenses | 548 | 543 | 535 | 1,033 |
| Accounts receivable | -14,285 | 11,634 | -29,722 | 44,321 |
| Inventories | 20,942 | 3,516 | 20,144 | 41,515 |
| Prepaid expenses and other current assets | 1,262 | -3,763 | 1,473 | 639 |
| Accounts payable | 7,132 | -22,098 | 6,535 | 11,816 |
| Accrued expenses and other liabilities | -12,322 | 6,631 | 10,801 | -11,309 |
| Net cash provided by (used in) operating activities | 12,849 | 52,469 | 68,526 | -4,019 |
| Capital expenditures | 9,726 | 10,656 | 10,439 | 17,404 |
| Purchases of strategic investments | - | 0 | 7,600 | 2,518 |
| Purchases of investments | 57,312 | 62,943 | 68,655 | 108,720 |
| Proceeds from sales or maturities of investments | 55,789 | 61,681 | 75,049 | 173,651 |
| Net cash (used in) investing activities | -11,249 | -11,918 | -11,645 | 45,009 |
| Proceeds from the exercise of stock options | 109 | 633 | 347 | 8,615 |
| Accelerated share repurchase of common stock | - | 0 | - | - |
| Share repurchase of common stock | 0 | 50,011 | 49,999 | 75,009 |
| Payment of taxes on net share settlement of equity awards | 7,591 | 694 | 1,426 | 20,924 |
| Proceeds from the issuance of common stock from employee stock purchase plan | - | 1,764 | 0 | 3,255 |
| Net cash (used in) financing activities | -7,482 | -48,308 | -51,078 | -84,063 |
| Effect of exchange rate on cash | 1 | -275 | 115 | -150 |
| (decrease) in cash and cash equivalents | -5,881 | -8,032 | 5,918 | -43,223 |
| Cash and cash equivalents at beginning of period | 104,813 | 112,845 | 150,150 | - |
| Cash and cash equivalents at end of period | 98,932 | 104,813 | 112,845 | - |